The evolving science
Why genetic interpretation changes as GWAS, biobanks, sequencing and polygenic research advance.
The human genome does not change when a new research paper is published.
Our ability to interpret it does.
That distinction is fundamental to Bioanalytix.
Genome-wide association studies
Genome-wide association studies, or GWAS, compare genetic variation across large groups of people to identify variants statistically associated with particular traits or diseases.
These studies have transformed human genetics.
Instead of studying only a handful of candidate genes, researchers can investigate variation across the genome and identify biological relationships that were previously unknown.
Larger biobanks
Large population datasets and biobanks increasingly combine genomic information with health records, biomarkers, imaging, lifestyle information and long-term outcomes.
As datasets grow, researchers can detect smaller genetic effects and study interactions among genetics, environment and disease.
Greater ancestral diversity is particularly important because much historical genomic research has been concentrated in populations of European ancestry.
Polygenic risk
Many common diseases and complex traits involve large numbers of variants.
A polygenic risk score, or PRS, combines information from many genetic variants into a statistical estimate of genetic susceptibility.
This can sometimes identify people whose inherited susceptibility is substantially above or below the population average.
But PRS performance depends on the underlying research population, phenotype definition, statistical method and other factors.
A polygenic score is therefore not a diagnosis or a complete estimate of risk.
Association is not causation
A variant identified by a GWAS may be associated with an outcome without itself causing that outcome.
It may be correlated with another causal variant, operate through a complex biological pathway or reflect other features of the study population.
Bioanalytix therefore distinguishes between:
observation → association → interpretation → potential relevance
rather than treating every published association as actionable.
Evidence can be upgraded — or downgraded
A finding may become stronger when it is replicated in larger and more diverse populations.
It may also become weaker when later studies fail to reproduce it or reveal important limitations.
This is why Bioanalytix is designed around governed evidence rather than a permanent lookup table.
The long-term opportunity is significant:
the DNA already exists; the evidence available to interpret it continues to improve.